HELMHOLTZ ZENTRUM FUR INFEKTIO has a total of 11 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Canada, United States and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are KOSAN BIOSCIENCES INC, GLIAMED INC and NORVARTIS AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 5 | |
#2 | United States | 3 | |
#3 | China | 1 | |
#4 | Republic of Korea | 1 | |
#5 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Basic materials chemistry | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Fermentation | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Heterocyclic compounds | |
#5 | Medical preparations | |
#6 | Special acyclic compounds | |
#7 | Microorganisms | |
#8 | Unspecified technologies | |
#9 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Guzman Carlos A | 3 |
#2 | Hoefle Gerhard | 3 |
#3 | Ebensen Thomas | 3 |
#4 | Morr Michael | 3 |
#5 | Steinmetz Heinrich | 2 |
#6 | Ferrer Manuel | 2 |
#7 | Timmis Kenneth | 2 |
#8 | Golyshin Peter | 2 |
#9 | Milkereit Goetz | 1 |
#10 | Sasse Florenz | 1 |
Publication | Filing date | Title |
---|---|---|
CN101142313A | Genes encoding the synthetic pathway for the production of disorazole |